At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PBM Psyence Biomedical Ltd
Trading 09-19 12:24:19 EDT
0.1324
-0.0066
-4.75%
High0.1538
Low0.1207
Vol17.67M
Open0.1530
D1 Closing0.1390
Amplitude23.81%
Mkt Cap2.21M
Tradable Cap1.43M
Total Shares16.70M
T/O2.40M
T/O Rate163.69%
Tradable Shares10.79M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-Psyence Biomed Enters Into Agreement To Acquire Stake In Psylabs
Psyence Group's Nasdaq-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for Its Phase Iib Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.